Kangyue Technology Co Ltd (300391) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.033x

Based on the latest financial reports, Kangyue Technology Co Ltd (300391) has a cash flow conversion efficiency ratio of 0.033x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-21.99 Million ≈ $-3.22 Million USD) by net assets (CN¥-667.62 Million ≈ $-97.69 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Kangyue Technology Co Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Kangyue Technology Co Ltd - Cash Flow Conversion Efficiency Trend (2009–2024)

This chart illustrates how Kangyue Technology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Kangyue Technology Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kangyue Technology Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
R. S. Software (India) Limited
NSE:RSSOFTWARE
-0.107x
Viet Phat Import Export Trading Investment JSC
VN:VPG
N/A
Lodestar Minerals Ltd
AU:LSR
3.339x
Crown Point Energy Inc
V:CWV
-0.370x
Brimstone Investment Corporation Ltd
JSE:BRT
0.023x
Vistry Group PLC
LSE:VTY
0.059x
Cielo Waste Solutions Corp
V:CMC
0.452x
Sejin T.S Co.Ltd
KQ:067770
0.010x

Annual Cash Flow Conversion Efficiency for Kangyue Technology Co Ltd (2009–2024)

The table below shows the annual cash flow conversion efficiency of Kangyue Technology Co Ltd from 2009 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Kangyue Technology Co Ltd worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥-421.36 Million
≈ $-61.66 Million
CN¥-75.30 Million
≈ $-11.02 Million
0.179x +223.33%
2023-12-31 CN¥1.02 Billion
≈ $148.87 Million
CN¥-147.43 Million
≈ $-21.57 Million
-0.145x -265.09%
2022-12-31 CN¥1.66 Billion
≈ $243.59 Million
CN¥-66.08 Million
≈ $-9.67 Million
-0.040x -127.65%
2021-12-31 CN¥1.61 Billion
≈ $235.49 Million
CN¥230.99 Million
≈ $33.80 Million
0.144x +534.18%
2020-12-31 CN¥1.45 Billion
≈ $212.10 Million
CN¥32.81 Million
≈ $4.80 Million
0.023x -23.69%
2019-12-31 CN¥751.95 Million
≈ $110.03 Million
CN¥22.30 Million
≈ $3.26 Million
0.030x -69.03%
2018-12-31 CN¥1.43 Billion
≈ $209.49 Million
CN¥137.09 Million
≈ $20.06 Million
0.096x +129.55%
2017-12-31 CN¥933.89 Million
≈ $136.66 Million
CN¥38.96 Million
≈ $5.70 Million
0.042x +184.07%
2016-12-31 CN¥362.88 Million
≈ $53.10 Million
CN¥-18.01 Million
≈ $-2.63 Million
-0.050x -144.06%
2015-12-31 CN¥363.91 Million
≈ $53.25 Million
CN¥40.98 Million
≈ $6.00 Million
0.113x +205.64%
2014-12-31 CN¥364.71 Million
≈ $53.37 Million
CN¥-38.88 Million
≈ $-5.69 Million
-0.107x -197.21%
2013-12-31 CN¥197.50 Million
≈ $28.90 Million
CN¥21.66 Million
≈ $3.17 Million
0.110x -35.51%
2012-12-31 CN¥172.54 Million
≈ $25.25 Million
CN¥29.34 Million
≈ $4.29 Million
0.170x -19.03%
2011-12-31 CN¥144.57 Million
≈ $21.15 Million
CN¥30.36 Million
≈ $4.44 Million
0.210x -8.89%
2010-12-31 CN¥117.43 Million
≈ $17.18 Million
CN¥27.07 Million
≈ $3.96 Million
0.230x -23.75%
2009-12-31 CN¥70.62 Million
≈ $10.33 Million
CN¥21.35 Million
≈ $3.12 Million
0.302x --

About Kangyue Technology Co Ltd

SHE:300391 China Drug Manufacturers - Specialty & Generic
Market Cap
$9.74 Million
CN¥66.56 Million CNY
Market Cap Rank
#27104 Global
#4746 in China
Share Price
CN¥0.19
Change (1 day)
+0.00%
52-Week Range
CN¥0.19 - CN¥4.63
All Time High
CN¥23.66
About

Changjiang Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the production and distribution of pharmaceuticals and photovoltaic equipment in China and internationally. It offers photovoltaic equipment, such as laminators and stack welding machines; and Chinese herbal medicines and hollow capsules, as well as engages in pharmaceutical distribution business. The company wa… Read more